Amneal And Amgen Dealt Same Sensipar Fate

Mixed Verdict On Key Patent Was Delivered In January

Croupier_Cards
Amneal challenged a vacation and remanding of an earlier favorable decision for its Sensipar ANDA • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin